Tag: Vertex Pharmaceuticals Inc
Sickle cell disease gene therapies Casgevy Lyfgenia insurance cost issues
The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from the debilitating disease, which overwhelmin [...]
Vertex non-opioid painkiller shows positive late-stage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019.Brian Snyder | ReutersVertex Pharmaceuticals on T [...]
Vertex non-opioid painkiller posts positive mid-stage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. Brian Snyder | ReutersShar [...]
First CRISPR gene-editing treatment approved in U.S.
Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test.Md Babul Hosen | Istock | Getty ImagesThe [...]
U.S. poised to approve breakthrough treatment
At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more t [...]
Walgreens, Coinbase, Duolingo, Ralph Lauren
A Walgreens store is seen on August 07, 2019 in Miami, Florida.Joe Raedle | Getty ImagesCheck out the companies making headlines in midday trading.Dox [...]
Cramer’s lightning round: Stay with Vertex Pharmaceuticals
Getty Images Holdings Inc: "I think down here at $4, I'm not a SPAC guy, okay, but this one may be actually worth looking at."Jim Cramer's Guide to In [...]
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
CNBC's Jim Cramer on Tuesday told investors his three stock picks from the worst- and best-performing stocks in the Nasdaq 100 during the first half o [...]
I’m sticking with Marvell Technology
Rocket Companies Inc: "I said the Fed was raising rates: you can't own anything in that area. And the Fed is still raising, so you still can't."Marvel [...]
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
Investors should consider purchasing stock of the first quarter's biggest losers if the market shows signs of recovering on its own, CNBC's Jim Cramer [...]
Stem cells may finally offer a cure for Type 1 diabetes
There are 537 million people around the world living with diabetes. And that number is growing. When people have Type 1 diabetes, the immune system at [...]
30-year-old female founder’s billion-dollar bet on CRISPR gene editing
Janice Chen (C) and her Mammoth Biosciences co-founders Trevor Martin (L) and Lucas Harrington (R). CRISPR gene editing pioneer and Nobel Prize winner [...]
Oppenheimer Holdings is cheap and should rally with the financials
Teladoc Health: "Too much competition in that business. Don't want to own it." Qualtrics International: "This company had a major upside surprise. [...]
Chewy, Biogen, Snowflake and extra
Signage is seen forward of the IPO for Chewy on the New York Inventory Alternate, June 14, 2019.Andrew Kelly | ReutersTake a look at the businesses [...]
Cramer’s lightning spherical: Invitae is a winner
Regenxbio: "It is a completely speculative state of affairs. Do not put even ... a small share of your belongings in it."Laredo Petroleum: "I am no [...]